Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.
暂无分享,去创建一个
D. Waters | J. Hung | L. Lacoste | J. Lam | D. Waters | J. Hung | C. B. Solymoss | G. Letchacovski | Glaci Letchacovski | C. Solymoss
[1] P. Théroux,et al. Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris. , 1994, The American journal of cardiology.
[2] M. Sugimachi,et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. , 1994, Circulation.
[3] D. Heistad,et al. Sick vessel syndrome. Can atherosclerotic arteries recover? , 1994, Circulation.
[4] R. Krauss,et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). , 1994, Circulation.
[5] D. Waters,et al. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. , 1994, Circulation.
[6] N J Wald,et al. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.
[7] D. Waters,et al. Oral Verapamil Inhibits Platelet Thrombus Formation in Humans , 1994, Circulation.
[8] Stanley Azen,et al. Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS) , 1993, Annals of Internal Medicine.
[9] C. Lau,et al. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients , 1993, The Lancet.
[10] J. Albers,et al. Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.
[11] V. Fuster,et al. Cod liver oil alters platelet-arterial wall response to injury in pigs. , 1992, Circulation research.
[12] G. Schuler,et al. Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease , 1992, Circulation.
[13] G. Davı̀,et al. Increased Thromboxane Biosynthesis in Type IIa Hypercholesterolemia , 1992, Circulation.
[14] G. Watts,et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) , 1992, The Lancet.
[15] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[16] H. Drexler,et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.
[17] J. Ritter,et al. Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease. , 1991, British journal of clinical pharmacology.
[18] M J Malloy,et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.
[19] J J Albers,et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.
[20] B. Rifkind,et al. The value of lowering cholesterol after myocardial infarction. , 1990, The New England journal of medicine.
[21] J P Matts,et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.
[22] K. Gould,et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.
[23] P Smith,et al. The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.
[24] J. Eidt,et al. Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.
[25] A. Angelini,et al. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. , 1989, European heart journal.
[26] E. Steinhagen-Thiessen,et al. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. , 1989, Eicosanoids.
[27] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[28] D H Blankenhorn,et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.
[29] V. Skinner,et al. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. , 1987, The Biochemical journal.
[30] J. Oates,et al. Drug therapy. Dipyrimadole , 1987 .
[31] J. Stamler,et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.
[32] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[33] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[34] M. Mancini,et al. Increased Fibrinogen Binding to Platelets from Patients with Familial Hypercholesterolemia , 1986, Arteriosclerosis.
[35] Roger A. Renfrew,et al. Lipid Research Clinics Program. , 1984, JAMA.
[36] M. Fisher,et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. , 1984, Circulation.
[37] A. Keys,et al. Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .
[38] J. White,et al. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. , 1980, The New England journal of medicine.
[39] R. Colman,et al. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia. , 1977, The Journal of laboratory and clinical medicine.
[40] R. Colman,et al. Platelet function in hyperlipoproteinemia. , 1974, The New England journal of medicine.